Resmed (RMD) is a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders such as sleep apnoea. RMD operates in over 65 countries through 16 direct offices and a network of distributors, including Australia, France, Germany, New Zealand, Singapore, the UK and the United States. Last week, RMD announced a 1H11 net profit of US$115.2 million, up 30.7% from a year earlier. Revenue increased 12.6% to US$359,953, driven by growth in flow generators and masks sales. Resmed said it expects growth of all of its products to continue to benefit from the growth in the sleep-disordered breathing market. RMD lost 2.1% last week, underperforming the share market, which gained 0.4%. Keep up to date with RMD and all Health Care Stocks with a free trial. January 31, 2011
Health Care Stocks News Resmed (RMD)
Resmed (RMD) is a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders such as sleep apnoea. RMD operates in over 65 countries through 16 direct offices and a network of distributors, including Australia, France, Germany, New Zealand, Singapore, the UK and the United States. Last week, RMD announced a 1H11 net profit of US$115.2 million, up 30.7% from a year earlier. Revenue increased 12.6% to US$359,953, driven by growth in flow generators and masks sales. Resmed said it expects growth of all of its products to continue to benefit from the growth in the sleep-disordered breathing market. RMD lost 2.1% last week, underperforming the share market, which gained 0.4%. Keep up to date with RMD and all Health Care Stocks with a free trial. 
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment